EVGN
Evogene (EVGN)
NASDAQ
$0.59+$0.03 (+5.60%)
Price as of Aug 21, 2026 7:59 PM EDT
  • $20.0M
    Market Cap
  • -56.90%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
ARK INVESTMENT MANAGEMENT LLC
41.92%
3.6M
-417,347 (-11.55%)
Dec 31, 2021
DELEK GROUP, LTD.
2.45%
211,144
-6,680 (-3.16%)
Jun 30, 2019
EIDELMAN VIRANT CAPITAL
1.36%
117,000
0 (0.00%)
Sep 30, 2022
CREDIT SUISSE AG/
0.66%
57,283
+57,283 (+100.00%)
Dec 31, 2021
UBS AG
0.59%
50,853
-762 (-1.50%)
Sep 30, 2014
DIMENSIONAL FUND ADVISORS LP
0.45%
39,044
0 (0.00%)
Mar 31, 2022
GOLDMAN SACHS GROUP INC
0.34%
29,114
+4,026 (+13.83%)
Dec 31, 2021

Current Ownership Distribution

  • Institutions31.6M (62.69%)
  • Mutual Funds17.5M (34.64%)
  • Insiders1.3M (2.67%)
  • Other0 (0.00%)

Insider Transactions

  • 2.67% (1.3M)
    Current InsiderOwnership (%, shares)
  • 1
    Number of InsiderBuying (last 12 months)
  • $41,943.00
    Amount of InsiderBuying (last 12 months)
  • 0
    Number of InsiderSelling (last 12 months)
  • $0.00
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
RECANATI LEON
Buy
Aug 04, 2026
$400,000.00
800,000
$0.50
883,886